YOUNG DAVID (Chief Executive Officer) exercised options at PROCESSA PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/4/2026ACC: 0000897069-26-000224
DirectorOfficer· Chief Executive Officer
Since Oct 2020
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
49.00 acquired · 49.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+49.00
Price / share
—
Trade value
—
% of position
0.6%
1/1/2026
8.70K→8.75K
Total
Net shares
+49.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2026 | M · Option Exercise | +49.00 | — | — | 0.6% | 8.70K | 8.75K |
| Total | +49.00 | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
49.00 shares
Shares
−49.00
Strike price
0
Held after
0.00
Exercisable
—
1/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock49.00 shares | 1/1/2026 | M · Option Exercise | −49.00 | 0 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned1.24K
Common Stock
IndirectShares owned432.00
Common Stock
IndirectShares owned742.00
Total
2.42K indirect2.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.24K | Indirect |
| Common Stock | 432.00 | Indirect |
| Common Stock | 742.00 | Indirect |
| Total | 2.42K | 2.42K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported